KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Cardlytics (CDLX) EBIAT (2017 - 2026)

Cardlytics filings provide 10 years of EBIAT readings, the most recent being -$4.5 million for Q1 2026.

  • Quarterly EBIAT rose 66.27% to -$4.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$94.7 million through Mar 2026, up 46.9% year-over-year, with the annual reading at -$103.5 million for FY2025, 45.33% up from the prior year.
  • EBIAT hit -$4.5 million in Q1 2026 for Cardlytics, up from -$8.2 million in the prior quarter.
  • Across five years, EBIAT topped out at $33.0 million in Q1 2022 and bottomed at -$378.3 million in Q4 2022.
  • Average EBIAT over 5 years is -$52.8 million, with a median of -$15.6 million recorded in 2024.
  • Peak annual rise in EBIAT hit 232.71% in 2022, while the deepest fall reached 3096.27% in 2022.
  • Cardlytics' EBIAT stood at -$378.3 million in 2022, then surged by 73.34% to -$100.8 million in 2023, then surged by 84.54% to -$15.6 million in 2024, then soared by 47.08% to -$8.2 million in 2025, then soared by 45.7% to -$4.5 million in 2026.
  • Per Business Quant, the three most recent readings for CDLX's EBIAT are -$4.5 million (Q1 2026), -$8.2 million (Q4 2025), and -$72.7 million (Q3 2025).